DeepMed Research

ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

Intrathecal Dexmedetomidine vs Epinephrine

Phase 4

Recruiting

Conditions: Cesarean Section
Anesthesia, Spinal

Interventions: Drug: Dexmedetomidine
Drug: Epinephrine
Drug: Standardized Spinal Mixture

First Posted Date: 2024-05-17

Last Posted Date: 2024-10-11

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 90

Registration Number: NCT06418308

Locations: 🇺🇸
Mount Sinai Hospital, New York, New York, United States

Assessment of Supportive Care and Educational Needs to Guide Quality Care Improvements for Patients With Locally Advanced and Metastatic Bladder Cancer

Recruiting

Conditions: Screening Tool
Focus Group

Interventions: Other: Screening tool

First Posted Date: 2024-05-14

Last Posted Date: 2024-05-14

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 210

Registration Number: NCT06412874

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Enhancing Access to Supportive Services for Women of Color with Metastatic Breast Cancer

Not Applicable

Recruiting

Conditions: Stage IV Breast Cancer AJCC V7
Metastatic Breast Cancer

Interventions: Behavioral: Phone sessions
Behavioral: ACCESS Supportive Care

First Posted Date: 2024-05-09

Last Posted Date: 2024-10-30

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 60

Registration Number: NCT06405828

Locations: 🇺🇸
Mount Sinai Hospital, New York, New York, United States

Virtual Reality (VR) Self-Hypnosis Software

Not Applicable

Not yet recruiting

Conditions: Neuropathic Pain
Neuralgia
Musculoskeletal Pain

Interventions: Device: Virtual Reality headset

First Posted Date: 2024-05-03

Last Posted Date: 2025-03-21

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 25

Registration Number: NCT06398847

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy

Phase 2

Recruiting

Conditions: Keloid

Interventions: Drug: Ritlecitinib

First Posted Date: 2024-04-18

Last Posted Date: 2024-09-30

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 30

Registration Number: NCT06373458

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Frequency of Glucose Monitoring in Labor

Not Applicable

Recruiting

Conditions: Neonatal Hypoglycemia

Interventions: Other: Fingerstick

First Posted Date: 2024-04-18

Last Posted Date: 2024-12-13

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 300

Registration Number: NCT06373432

Locations: 🇺🇸
Mount Sinai West Hospital, New york, New York, United States

A Light Exposure Tracker Designed to Improve Circadian Rhythms - Aim 1

Not Applicable

Recruiting

Conditions: Alzheimer's Disease
Mild Cognitive Impairment

Interventions: Device: Light goggles
Device: Orange glasses

First Posted Date: 2024-04-10

Last Posted Date: 2024-04-10

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 20

Registration Number: NCT06356337

Locations: 🇺🇸
Light and Health Research Center, Menands, New York, United States

USCOM in Newly Diagnosed FGR Cases

Recruiting

Conditions: USCOM
Fetal Growth Restriction

Interventions: Device: USCOM

First Posted Date: 2024-04-02

Last Posted Date: 2025-02-10

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 100

Registration Number: NCT06343051

Locations: 🇺🇸
Mount Sinai Hospital, New York, New York, United States

Precision Medicine Study

Recruiting

Conditions: Multiple Myeloma

First Posted Date: 2024-03-29

Last Posted Date: 2024-08-05

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 100

Registration Number: NCT06338150

Locations: 🇺🇸
Mount Sinai Health System, New York, New York, United States

Bimekizumab in Plaque Psoriasis

Phase 4

Recruiting

Conditions: Plaque Psoriasis

Interventions: Drug: Bimekizumab

First Posted Date: 2024-03-28

Last Posted Date: 2024-07-12

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 60

Registration Number: NCT06336343

Locations: 🇺🇸
Windsor Dermatology - Psoriasis Treatment Center of Central New Jersey, East Windsor, New Jersey, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy